Trials / Completed
CompletedNCT03330314
Molar Potency Study of HM12460A in Healthy Subjects
An Open Label, Fixed-Sequence, Glucose Clamp Study to Compare Molar Potency of HM12460A and Insulin Glargine in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This is a phase 1 study to assess and compare molar potency of HM12460A and glargine in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | HM12460A | HM12460A is a long-acting insulin |
Timeline
- Start date
- 2017-10-24
- Primary completion
- 2018-02-08
- Completion
- 2018-02-08
- First posted
- 2017-11-06
- Last updated
- 2020-08-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03330314. Inclusion in this directory is not an endorsement.